Bullisch
$56.20
Szenariopreis
$62.460
-5.434 (-8.70%)Zum Schluss
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Establishment Labs Holdings Inc is a good buy right now due to its current price of $63.8, which is significantly below the average analyst price target of $105. The company has shown a strong gross margin of 70.64% in Q2 2026, indicating solid profitability potential as it continues to innovate in the breast augmentation market. However, the main risk is the high forward P/E ratio of 204.08, suggesting that the stock is priced for significant growth that may not materialize immediately.
TD Cowen
$95
2026-10-26
TD Cowen
2026-10-26
Kursziel
$95
Citi
$92
2026-08-13
Citi
2026-08-13
Kursziel
$92
Canaccord
$105
2026-08-07
Canaccord
2026-08-07
Kursziel
$105
Mizuho
$105
2026-07-15
Mizuho
2026-07-15
Kursziel
$105
Citi
$92
2026-07-08
Citi
2026-07-08
Kursziel
$92
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Latest Wall Street Rating Updates

Establishment Labs Receives FDA Approval for Expanded Breast Implant Range

Establishment Labs Presents New Clinical Data on Breast Tissue Preservation

GLP-1 Drugs Boost Demand for Breast Augmentation

Global Medical Aesthetics Market Poised for Significant Growth
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is a good buy right now due to its current price of $63.8, which is significantly below the average analyst price target of $105. The company has shown a strong gross margin of 70.64% in Q2 2026, indicating solid profitability potential as it continues to innovate in the breast augmentation market. However, the main risk is the high forward P/E ratio of 204.08, suggesting that the stock is priced for significant growth that may not materialize immediately.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.